MHRA alert Archives | Dispensing Doctors' Association

November 11th 2025

Alert: Emylif 50mg orodispersible film

One batch of Emylif 50mg orodispersible film is being recalled as a precautionary measure. This is due to concerns about impurities at 24 months’ shelf life. The affected batch is as follows: Batch No. Expiry Date Pack Size

August 27th 2025

Alert: Ipca Laboratories UK various products

Ipca Laboratories UK Ltd has advised that the Patient Information Leaflet (PIL) in the products listed below do not contain all the required safety information. This issue impacts all current batches of the impacted products. Please see detail

August 22nd 2025

Alert: fexofenadine hydrochloride 120mg film-coated tablets

Chanelle Medical Unlimited Company has informed the MHRA of an error with the European Article Number (EAN) / Global Trade Item Number (GTIN) barcode affecting 26 batches of fexofenadine hydrochloride 120mg film-coated tablets, distributed by He

Hot topics

DM Zone news HR Zone news Clinical guidance news Political News Scotland Wales Rurality Supply Shortages COVID19

August 15th 2025

Alert: levetiracetam Accord 100mg/ml oral solution

Accord Healthcare Limited, UK has advised of missing PIL and SPC information in four batches of levetiracetam Accord 100mg/ml oral solution. The affected batches are: Batch No. Expiry Date Pack Size First Distributed

August 7th 2025

Alert: topiramate Zydus Pharmaceuticals UK 20mg/ml oral solution

Zydus Pharmaceuticals UK Ltd has advised that there are missing instructions for use on the outer carton of three batches of topiramate Zydus Pharmaceuticals UK 20mg/ml oral solution. Affected batches are not being recalled. The affected batch

August 5th 2025

Alert: Leo Pharma fucidin 250mg tabs

Leo Laboratories Ltd (Leo Pharma) is recalling one batch of fucidin 250 mg tablets (sodium fusidate).The affected batch is: Batch No. Expiry Date Pack Size First Distributed D00993 31/01/2026 10 x 10 13

August 1st 2025

Alert: olmesartan medoxomil 10mg & 20mg film-coated tablets

Two batches of Jubilant Pharmaceuticals’ olmesartan medoxomil 10mg film-coated tablets and one of the 20mg strength contain incorrect Patient Information leaflets (PIL), the MHRA has advised.The affected batches are: 10mg film-coated tablets